Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;65:264-75.
doi: 10.1016/j.neubiorev.2016.03.015. Epub 2016 Apr 9.

Serotonergic Perturbations in Dystonia Disorders-A Systematic Review

Affiliations
Review

Serotonergic Perturbations in Dystonia Disorders-A Systematic Review

M Smit et al. Neurosci Biobehav Rev. .

Abstract

Dystonia is a hyperkinetic movement disorder characterized by sustained or intermittent muscle contractions. Emerging data describe high prevalences of non-motor symptoms, including psychiatric co-morbidity, as part of the phenotype of dystonia. Basal ganglia serotonin and serotonin-dopamine interactions gain attention, as imbalances are known to be involved in extrapyramidal movement and psychiatric disorders. We systematically reviewed the literature for human and animal studies relating to serotonin and its role in dystonia. An association between dystonia and the serotonergic system was reported with decreased levels of 5-hydroxyindolacetic acid, the main metabolite of serotonin. A relation between dystonia and drugs affecting the serotonergic system was described in 89 cases in 49 papers. Psychiatric co-morbidity was frequently described, but likely underestimated as it was not systematically examined. Currently, there are no good (pharmaco)therapeutic options for most forms of dystonia or associated non-motor symptoms. Further research using selective serotonergic drugs in appropriate models of dystonia is required to establish the role of the serotonergic system in dystonia and to guide us to new therapeutic strategies.

Keywords: 5-HIAA; Dystonia; Neurotransmitters; Non-motor; Psychiatric disorder; Serotonin.

Similar articles

See all similar articles

Cited by 3 articles

Substances

LinkOut - more resources

Feedback